Abstract
A rabbit model of invasive aspergillosis has been used to investigate the pathogenesis of Aspergillus infection in the immunosuppressed host. The animals received hydrocortisone daily and a single dose of cyclophosphamide 2 days prior to intratracheal instillation of conidia from Aspergillus fumigatus. Bronchoalveolar lavage (BAL) was performed in 3 infected and 2 control saline treated animals sacrificed on days 1, 2, 4, 7 and 10 following inoculation. Infective load within the lung was quantified using an assay for chitin which is an important component of fungal cell walls (in particular the hyphal cell wall) and is not present in vertebrate tissue. The total BAL white cell count did not discriminate between infected and saline treated animals and Aspergillus was cultured from one lavage specimen only. Infected animals developed a marked neutrophil alveolitis by day 2 in contrast to a near total absence of neutrophils in the lavages of the control animals. Phagocytosis of conidia by alveolar macrophages was prominent but did not prevent progressive infection as confirmed by measurement of lung chitin. This pattern of cellular response within the alveolar airspace reflects the complex nature of the response to Aspergillus infection in the immunosuppressed host.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Fraser DW, Ward JI, Ajello L, Plikaytis BD. Aspergillosis and other systemic mycoses. JAMA 1979; 242: 1631–5.
Aisner J, Schimpff SC, Wiernik PH. Treatment of invasive aspergillosis: relation of early diagnosis and treatment response. Ann Intern Med 1977; 86: 539–43.
Myer RD, Young LS, Armstrong D, Yu B. Aspergillosis complicating neoplastic disease. Am J Med 1973; 54: 6–15.
Young RC, Bennett JE. Invasive aspergillosis. Absence of detectable antibody response. Am Rev Resp Dis 1971; 104: 710–6.
Gerson SL, Talbot GH, Hurwitz S et al. Prolonged granulocytopenia: The major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Int Med 1984; 100: 345–51.
Merkow LP, Epstein SM, Sidransky H, Verney E, Pardo M. The pathogenesis of experimental pulmonary aspergillosis. Am J Path 1971; 62: 57–66.
Sandu DK, Sandu RS, Damodaran VN, Randhawa HS. Effect of cortisone on bronchopulmonary aspergillosis in mice exposed to spores of various Aspergillus species. Sabouraudia 1970; 8: 32–8.
Andrews CP, Weiner MH. Immunodiagnosis of invasive pulmonary aspergillosis in rabbits. Am Rev Resp Dis 1981; 124: 60–4.
De Repentigny L, Boushira M, Ste-Marie L, Bosisio G. Detection of galactomannan antigenemia by enzyme immunoassay in experimental invasive aspergillosis. J Clin Microbiol 1987; 25: 863–7.
Schaffner A, Douglas H, Braude A. Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. J Clin Invest 1982; 69: 617–631.
Lehmann PF, White LO. Chitin assay used to demonstrate renal localization and cortisone enhanced growth of Aspergillus fumigates mycelium in mice. Infect Immun 1975; 12: 987–92.
Cohen AB, Batra G, Peterson R, Podany J, Nguyen D. Size of the pool of alveolar neutrophils in normal rabbit lung. J Appl Physiol 1979; 47: 440–4.
Gell PGH, Coombs RRA, Lachman PJ. Clinical aspects of Immunology. 3rd ed. Oxford: Blackwell Scientific, 1975: Ch.4.
Turner-Warwick ME, Haslam PL. Clinical applications of bronchoalveolar lavage: an interim review. Br J Dis Chest 1986; 80: 105–19.
Thompson J, van Furth R. The effect of glucocorticosteroids on the kinetics of mononuclear phagocytes. J Exp Med 1970; 131: 429–42.
Epstein SM, Verney E, Miale TD, Sidransky H. Studies on the pathogenesis of experimental pulmonary aspergillosis. Am J Path 1967; 51: 769–813.
Waldorf AR, Levitz SM, Diamond RD. In vitro bronchoalveolar macrophage defense against Rhizopus orzae and Aspergillus fumigatus. J Infect Dis 1984; 150: 752–60.
Al-Doory Y, Wagner GE. Aspergillosis. Illinois: Charles C Thomas. 1985: 228.
Spreadbury CL, Krausz T, Pervez S, Cohen J. Invasive Aspergillosis: clinical and pathological description of a new animal model. J Med Vet Mycol 1989; 27: 5–15.
Diamond RD, Bennett JE. Growth of Cryptococcus neoformans within human macrophages in vitro. Infect Immun 1973; 7: 231–6.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chilvers, E.R., Spreadbury, C.L. & Cohen, J. Bronchoalveolar lavage in an immunosuppressed rabbit model of invasive pulmonary aspergillosis. Mycopathologia 108, 163–171 (1989). https://doi.org/10.1007/BF00436221
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00436221